Simon Björklund, CEO of Bioglan, a Swedish CDMO owned by Reig Jofre, explains the company’s twofold business model of developing and manufacturing products for local and international clients. He highlights the advantages of manufacturing and operating in Sweden, while emphasizing his future vision of developing and out-licensing Bioglan’s own products.
From a strategic point of view, being located in the south of Sweden has proven to be an advantage. The Skåne region is great, with several pharma and medtech companies having a huge footprint in the area
